In recent decades, numerous advances have highlighted the mechanisms of the disease, as technological advances have led to the development of automated insulin delivery (AID) systems, aiming to improve the metabolic control and the quality of life of patients with T1D. Here, INS is linked to type 1 diabetes mellitus.